NR607 WEEK 2 STANDARDIZED PROCEDURE – SEROTONIN
SYNDROME PSYCHIATRIC EMERGENCY: QUESTIONS AND
CORRECT ANSWERS (VERIFIED ANSWERS) PLUS RATIONALES 2026
Q&A | INSTANT DOWNLOAD PDF
Core Domains:
Serotonin Syndrome Pathophysiology and Etiology
Hunter Toxicity Criteria and Diagnostic Assessment
Differentiation from Neuroleptic Malignant Syndrome (NMS)
Clinical Presentation and Severity Grading
Immediate Emergency Management and Stabilization
Pharmacological Interventions and Antidotal Therapy
Special Populations (Geriatric, Pediatric, Pregnant)
Prevention and Patient Education
PMHNP Treatment Plan and Follow-up
Interprofessional Collaboration and Documentation
This comprehensive standardized procedure guide is designed to prepare Psychiatric-Mental
Health Nurse Practitioner (PMHNP) students for the NR607 Week 2 assessment on Serotonin
Syndrome as a Psychiatric Emergency. The examination covers the diagnosis, assessment,
management, and PMHNP treatment plan for serotonin syndrome, a potentially life-threatening
condition resulting from excessive serotonergic activity. Questions address pathophysiology,
clinical presentation using the Hunter Toxicity Criteria, differentiation from Neuroleptic
Malignant Syndrome (NMS), emergency management protocols, pharmacological interventions
including cyproheptadine, and the development of comprehensive PMHNP treatment plans.
Each item includes a verified correct answer accompanied by a detailed rationale to reinforce
learning and support exam preparation for the 2026 academic year at Chamberlain University.
,SECTION ONE: QUESTIONS 1 – 50
Question 1
A patient presents with agitation, diaphoresis, and inducible clonus in the lower extremities after
starting paroxetine and tramadol. Which diagnostic criteria are most accurate for diagnosing
serotonin syndrome?
A. Sternbach Criteria
B. Radomski Criteria
C. Hunter Toxicity Criteria
D. DSM-5 Criteria
C. Hunter Toxicity Criteria
RATIONALE: The Hunter Toxicity Criteria Decision Rules are accepted as the most
accurate diagnostic tool for serotonin syndrome, with 84% sensitivity and 97% specificity
compared to the gold standard of a medical toxicologist's diagnosis. The Hunter Criteria are
preferred over Sternbach and Radomski criteria as they are more specific and have been
validated in clinical settings.
Question 2
According to the Hunter Toxicity Criteria, which combination of findings is required for a
diagnosis of serotonin syndrome?
A. History of recent exposure to a serotonergic agent plus at least one specific finding
B. Fever and muscle rigidity only
C. Hyperthermia and bradycardia
D. Dry mucous membranes and urinary retention
A. History of recent exposure to a serotonergic agent plus at least one specific finding
RATIONALE: The Hunter Criteria require a history of recent exposure to a serotonergic
agent plus at least one of the following: spontaneous clonus, inducible clonus with agitation or
diaphoresis, ocular clonus with agitation or diaphoresis, tremor and hyperreflexia, or hypertonia
with temperature >38°C and ocular or inducible clonus.
Question 3
A patient with a history of stable dosing of sertraline is unlikely to develop serotonin syndrome
spontaneously. What does this indicate?
,A. The patient is immune to serotonin syndrome
B. A medication change or drug interaction is typically required
C. Sertraline does not cause serotonin syndrome
D. The patient should stop taking sertraline immediately
B. A medication change or drug interaction is typically required
RATIONALE: Patients on a stable dose of a serotonergic agent are unlikely to develop
serotonin syndrome spontaneously. Serotonin syndrome typically occurs after initiation of a
medication, dose increase, pharmacologic change that decreases metabolism, overdose, or drug-
drug interaction. A stable regimen that is tolerated does not precipitate serotonin syndrome.
Question 4
Which of the following is NOT a precipitant of serotonin syndrome?
A. SSRI initiation
B. MAOI with SSRI combination
C. Stable dose of sertraline for 2 years
D. Linezolid added to paroxetine
C. Stable dose of sertraline for 2 years
RATIONALE: Serotonin syndrome is precipitated by initiation or dose increase of a
serotonergic agent, pharmacologic change that decreases metabolism, overdose, or drug-drug
interactions. A stable dose of a serotonergic agent that the patient has tolerated does not
precipitate serotonin syndrome.
Question 5
Which medication class is more likely to cause severe serotonin toxicity?
A. SSRIs
B. MAOIs
C. SNRIs
D. Tricyclic antidepressants
B. MAOIs
RATIONALE: SSRIs rarely cause severe serotonin toxicity, while medications that inhibit
MAO are more likely to cause severe serotonin syndrome. MAOIs increase serotonin levels
more significantly and can lead to life-threatening serotonin toxicity, especially when combined
with other serotonergic agents.
, Question 6
A patient presents with ocular clonus, agitation, and diaphoresis after starting fluoxetine and
tramadol. According to the Hunter Criteria, this presentation is consistent with:
A. Neuroleptic malignant syndrome
B. Serotonin syndrome
C. Anticholinergic toxicity
D. Malignant hyperthermia
B. Serotonin syndrome
RATIONALE: Ocular clonus with agitation and diaphoresis is one of the specific findings in
the Hunter Criteria for serotonin syndrome. The combination of a serotonergic agent (fluoxetine)
with tramadol (which has serotonergic properties) creates risk for serotonin syndrome. Ocular
clonus is a hallmark of serotonin toxicity.
Question 7
What is the onset of serotonin syndrome after initiation or change of a serotonergic medication?
A. Days to weeks
B. Within 24 hours
C. 1-2 weeks
D. Months
B. Within 24 hours
RATIONALE: Serotonin syndrome typically occurs within 24 hours of starting or changing
a serotonergic medication. This rapid onset distinguishes it from Neuroleptic Malignant
Syndrome (NMS), which has a slower onset of 1-2 weeks after starting or changing therapy. The
rapid onset is an important diagnostic feature.
Question 8
A patient with serotonin syndrome has a temperature of 40.1°C, muscle rigidity, and autonomic
instability. This represents:
A. Mild serotonin syndrome
B. Moderate serotonin syndrome
C. Severe serotonin syndrome
D. No serotonin syndrome
C. Severe serotonin syndrome
SYNDROME PSYCHIATRIC EMERGENCY: QUESTIONS AND
CORRECT ANSWERS (VERIFIED ANSWERS) PLUS RATIONALES 2026
Q&A | INSTANT DOWNLOAD PDF
Core Domains:
Serotonin Syndrome Pathophysiology and Etiology
Hunter Toxicity Criteria and Diagnostic Assessment
Differentiation from Neuroleptic Malignant Syndrome (NMS)
Clinical Presentation and Severity Grading
Immediate Emergency Management and Stabilization
Pharmacological Interventions and Antidotal Therapy
Special Populations (Geriatric, Pediatric, Pregnant)
Prevention and Patient Education
PMHNP Treatment Plan and Follow-up
Interprofessional Collaboration and Documentation
This comprehensive standardized procedure guide is designed to prepare Psychiatric-Mental
Health Nurse Practitioner (PMHNP) students for the NR607 Week 2 assessment on Serotonin
Syndrome as a Psychiatric Emergency. The examination covers the diagnosis, assessment,
management, and PMHNP treatment plan for serotonin syndrome, a potentially life-threatening
condition resulting from excessive serotonergic activity. Questions address pathophysiology,
clinical presentation using the Hunter Toxicity Criteria, differentiation from Neuroleptic
Malignant Syndrome (NMS), emergency management protocols, pharmacological interventions
including cyproheptadine, and the development of comprehensive PMHNP treatment plans.
Each item includes a verified correct answer accompanied by a detailed rationale to reinforce
learning and support exam preparation for the 2026 academic year at Chamberlain University.
,SECTION ONE: QUESTIONS 1 – 50
Question 1
A patient presents with agitation, diaphoresis, and inducible clonus in the lower extremities after
starting paroxetine and tramadol. Which diagnostic criteria are most accurate for diagnosing
serotonin syndrome?
A. Sternbach Criteria
B. Radomski Criteria
C. Hunter Toxicity Criteria
D. DSM-5 Criteria
C. Hunter Toxicity Criteria
RATIONALE: The Hunter Toxicity Criteria Decision Rules are accepted as the most
accurate diagnostic tool for serotonin syndrome, with 84% sensitivity and 97% specificity
compared to the gold standard of a medical toxicologist's diagnosis. The Hunter Criteria are
preferred over Sternbach and Radomski criteria as they are more specific and have been
validated in clinical settings.
Question 2
According to the Hunter Toxicity Criteria, which combination of findings is required for a
diagnosis of serotonin syndrome?
A. History of recent exposure to a serotonergic agent plus at least one specific finding
B. Fever and muscle rigidity only
C. Hyperthermia and bradycardia
D. Dry mucous membranes and urinary retention
A. History of recent exposure to a serotonergic agent plus at least one specific finding
RATIONALE: The Hunter Criteria require a history of recent exposure to a serotonergic
agent plus at least one of the following: spontaneous clonus, inducible clonus with agitation or
diaphoresis, ocular clonus with agitation or diaphoresis, tremor and hyperreflexia, or hypertonia
with temperature >38°C and ocular or inducible clonus.
Question 3
A patient with a history of stable dosing of sertraline is unlikely to develop serotonin syndrome
spontaneously. What does this indicate?
,A. The patient is immune to serotonin syndrome
B. A medication change or drug interaction is typically required
C. Sertraline does not cause serotonin syndrome
D. The patient should stop taking sertraline immediately
B. A medication change or drug interaction is typically required
RATIONALE: Patients on a stable dose of a serotonergic agent are unlikely to develop
serotonin syndrome spontaneously. Serotonin syndrome typically occurs after initiation of a
medication, dose increase, pharmacologic change that decreases metabolism, overdose, or drug-
drug interaction. A stable regimen that is tolerated does not precipitate serotonin syndrome.
Question 4
Which of the following is NOT a precipitant of serotonin syndrome?
A. SSRI initiation
B. MAOI with SSRI combination
C. Stable dose of sertraline for 2 years
D. Linezolid added to paroxetine
C. Stable dose of sertraline for 2 years
RATIONALE: Serotonin syndrome is precipitated by initiation or dose increase of a
serotonergic agent, pharmacologic change that decreases metabolism, overdose, or drug-drug
interactions. A stable dose of a serotonergic agent that the patient has tolerated does not
precipitate serotonin syndrome.
Question 5
Which medication class is more likely to cause severe serotonin toxicity?
A. SSRIs
B. MAOIs
C. SNRIs
D. Tricyclic antidepressants
B. MAOIs
RATIONALE: SSRIs rarely cause severe serotonin toxicity, while medications that inhibit
MAO are more likely to cause severe serotonin syndrome. MAOIs increase serotonin levels
more significantly and can lead to life-threatening serotonin toxicity, especially when combined
with other serotonergic agents.
, Question 6
A patient presents with ocular clonus, agitation, and diaphoresis after starting fluoxetine and
tramadol. According to the Hunter Criteria, this presentation is consistent with:
A. Neuroleptic malignant syndrome
B. Serotonin syndrome
C. Anticholinergic toxicity
D. Malignant hyperthermia
B. Serotonin syndrome
RATIONALE: Ocular clonus with agitation and diaphoresis is one of the specific findings in
the Hunter Criteria for serotonin syndrome. The combination of a serotonergic agent (fluoxetine)
with tramadol (which has serotonergic properties) creates risk for serotonin syndrome. Ocular
clonus is a hallmark of serotonin toxicity.
Question 7
What is the onset of serotonin syndrome after initiation or change of a serotonergic medication?
A. Days to weeks
B. Within 24 hours
C. 1-2 weeks
D. Months
B. Within 24 hours
RATIONALE: Serotonin syndrome typically occurs within 24 hours of starting or changing
a serotonergic medication. This rapid onset distinguishes it from Neuroleptic Malignant
Syndrome (NMS), which has a slower onset of 1-2 weeks after starting or changing therapy. The
rapid onset is an important diagnostic feature.
Question 8
A patient with serotonin syndrome has a temperature of 40.1°C, muscle rigidity, and autonomic
instability. This represents:
A. Mild serotonin syndrome
B. Moderate serotonin syndrome
C. Severe serotonin syndrome
D. No serotonin syndrome
C. Severe serotonin syndrome
